vatalanib has been researched along with jnj 10198409 in 1 studies
Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (jnj 10198409) | Trials (jnj 10198409) | Recent Studies (post-2010) (jnj 10198409) |
---|---|---|---|---|---|
276 | 42 | 98 | 6 | 0 | 4 |
Protein | Taxonomy | vatalanib (IC50) | jnj 10198409 (IC50) |
---|---|---|---|
Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.022 | |
Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.1 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.378 | |
Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.0038 | |
Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.185 | |
Platelet-derived growth factor receptor alpha | Homo sapiens (human) | 0.045 | |
Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 3.1 | |
Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 3.1 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 3.1 | |
Casein kinase I isoform alpha | Homo sapiens (human) | 7.2 | |
Casein kinase I isoform delta | Homo sapiens (human) | 7.2 | |
Casein kinase I isoform epsilon | Homo sapiens (human) | 7.2 | |
Casein kinase I isoform gamma-2 | Homo sapiens (human) | 7.2 | |
Casein kinase I isoform gamma-1 | Homo sapiens (human) | 7.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
1 other study(ies) available for vatalanib and jnj 10198409
Article | Year |
---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |